Marcel Raspe

Marcel Raspe is the Team Manager of Radiochemical Labs at NRG, where they manage daily operations and project management for an ISO17025 accredited laboratory. Previously, Marcel worked as an Analytical Chemist R&D at Mallinckrodt Pharmaceuticals, contributing to the HEU to LEU target conversion for Mo-99 production. Marcel completed a Ph.D. at the University of Amsterdam, focusing on antigen processing and neurodegenerative diseases, and served as a Postdoctoral Research Fellow at Antoni van Leeuwenhoek, where they specialized in oncology and epigenetics. Marcel holds a Master's degree in Biochemistry from the University of Groningen.